Revolutionizing Patient Recruitment with AI: myTomorrows' Advanced Platform for Clinical Trials
myTomorrows, a leader in global health technology, has recently unveiled an advanced AI-powered platform aimed at facilitating patient recruitment for clinical trials. This groundbreaking technology is designed to streamline the recruitment process for clinical trials by providing precise matching of patients based on their medical conditions to available trials. The platform's core feature is an AI-powered pre-screening tool, boasting an impressive accuracy rate of 98% for fully automated trial eligibility matching. This far exceeds industry standards and performance metrics for individuals with medical backgrounds.
Navigating the Clinical Trial Landscape
The complexity of the clinical trial landscape has increased significantly due to the rise of various disease subtypes and the registration of over 500,000 clinical trials worldwide. Treating physicians often find it challenging to sift through this wealth of information to find suitable trials for their patients. Consequently, this challenge creates a bottleneck in trial recruitment and retention efforts for sponsors and clinical sites.
Recognizing this pressing issue, myTomorrows has developed a multi-faceted approach to enhance the recruitment process. Their AI platform aggregates trial data from prominent global registries, including ClinicalTrials.gov, EudraCT, and ISRCTN. By comparing patient medical data against trial criteria, the platform allows physicians to unearth suitable trial matches quickly. With the new AI functionality, physicians can identify eligible trials in a matter of minutes rather than hours, thereby optimizing workflow and increasing efficiency.
Ensuring Security and Compliance
Another significant advantage of the myTomorrows platform is its commitment to maintaining high-security standards. It is ISO 27001-certified and compliant with GPDR and HIPAA regulations, enabling the secure handling of both structured and unstructured medical data from Electronic Health Records (EHRs). The automated eligibility check not only accelerates the matching process but also assures that doctors can confidently refer patients to clinical trials.
Empowering Physicians and Patients
myTomorrows’ platform is designed to benefit all parties involved in the clinical trial process. The improved communication and management functionalities simplify the referral process, allowing trial sites to easily access pre-screened patients. Additionally, a new feature that provides the latest clinical trial data, including insights into efficacy and safety, helps inform physicians' decision-making when considering trial options for their patients.
Dr. Michel van Harten, CEO of myTomorrows, emphasized the importance of this transition for physicians, stating, "A better match results in reduced workloads and increases the chances of successful enrollment for clinical trials. This change can lead to improved patient outcomes through better access to innovative therapies."
Leading the Future of Clinical Trials
The impressive capabilities of this next-generation AI platform were recently highlighted at the SCOPE Summit in Orlando, Florida—a key event for clinical operations executives focused on advancing innovation in clinical trials. myTomorrows showcased how their platform utilizes state-of-the-art large language models (LLMs) to assist healthcare professionals efficiently and accurately navigate trial options.
With plans to make the platform available to various healthcare stakeholders—including hospitals, Clinical Research Organizations (CROs), and health tech firms—myTomorrows is paving the way for a future where clinical trials become more accessible. Their technology facilitates large-scale patient screenings seamlessly integrated with existing healthcare workflows.
A Commitment to Accessibility and Efficiency
In essence, myTomorrows is driven by a mission to eliminate barriers in accessing pre-approval treatment options for patients. Through their innovative platform, the company aims to provide faster, more accurate, and efficient pathways for patients in need of potential treatments. The organization has already positively impacted over 14,000 patients and 2,200 physicians across 125 countries, demonstrating their commitment to advancing healthcare.
As myTomorrows moves forward with its AI advancements, it promises to be at the forefront of transforming clinical research, facilitating a more inclusive environment for diverse patient populations and improving overall trial participation. For those interested in experiencing this precision technology, myTomorrows invites physicians to explore their platform through various available registration options.
Navigating the Clinical Trial Landscape
The complexity of the clinical trial landscape has increased significantly due to the rise of various disease subtypes and the registration of over 500,000 clinical trials worldwide. Treating physicians often find it challenging to sift through this wealth of information to find suitable trials for their patients. Consequently, this challenge creates a bottleneck in trial recruitment and retention efforts for sponsors and clinical sites.
Recognizing this pressing issue, myTomorrows has developed a multi-faceted approach to enhance the recruitment process. Their AI platform aggregates trial data from prominent global registries, including ClinicalTrials.gov, EudraCT, and ISRCTN. By comparing patient medical data against trial criteria, the platform allows physicians to unearth suitable trial matches quickly. With the new AI functionality, physicians can identify eligible trials in a matter of minutes rather than hours, thereby optimizing workflow and increasing efficiency.
Ensuring Security and Compliance
Another significant advantage of the myTomorrows platform is its commitment to maintaining high-security standards. It is ISO 27001-certified and compliant with GPDR and HIPAA regulations, enabling the secure handling of both structured and unstructured medical data from Electronic Health Records (EHRs). The automated eligibility check not only accelerates the matching process but also assures that doctors can confidently refer patients to clinical trials.
Empowering Physicians and Patients
myTomorrows’ platform is designed to benefit all parties involved in the clinical trial process. The improved communication and management functionalities simplify the referral process, allowing trial sites to easily access pre-screened patients. Additionally, a new feature that provides the latest clinical trial data, including insights into efficacy and safety, helps inform physicians' decision-making when considering trial options for their patients.
Dr. Michel van Harten, CEO of myTomorrows, emphasized the importance of this transition for physicians, stating, "A better match results in reduced workloads and increases the chances of successful enrollment for clinical trials. This change can lead to improved patient outcomes through better access to innovative therapies."
Leading the Future of Clinical Trials
The impressive capabilities of this next-generation AI platform were recently highlighted at the SCOPE Summit in Orlando, Florida—a key event for clinical operations executives focused on advancing innovation in clinical trials. myTomorrows showcased how their platform utilizes state-of-the-art large language models (LLMs) to assist healthcare professionals efficiently and accurately navigate trial options.
With plans to make the platform available to various healthcare stakeholders—including hospitals, Clinical Research Organizations (CROs), and health tech firms—myTomorrows is paving the way for a future where clinical trials become more accessible. Their technology facilitates large-scale patient screenings seamlessly integrated with existing healthcare workflows.
A Commitment to Accessibility and Efficiency
In essence, myTomorrows is driven by a mission to eliminate barriers in accessing pre-approval treatment options for patients. Through their innovative platform, the company aims to provide faster, more accurate, and efficient pathways for patients in need of potential treatments. The organization has already positively impacted over 14,000 patients and 2,200 physicians across 125 countries, demonstrating their commitment to advancing healthcare.
As myTomorrows moves forward with its AI advancements, it promises to be at the forefront of transforming clinical research, facilitating a more inclusive environment for diverse patient populations and improving overall trial participation. For those interested in experiencing this precision technology, myTomorrows invites physicians to explore their platform through various available registration options.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.